A liquid crystal is a paradox — a fluid that flows like a liquid yet holds internal order like a crystal. Cinnamix is built on one. Potassium cinnamate is not simply dissolved in water; it is held inside an ordered, self-assembling lipid matrix made from GCC. That structure is not packaging. It is the technology.
–4 minute read–
A fourth state of matter, briefly
We are taught three states of matter: solid, liquid, gas. There is a fourth that medicine has been slow to exploit — the liquid crystal: a phase that flows like a liquid but retains the long-range molecular order of a crystal.
The kind that matters here is the lyotropic liquid crystal — order created not by temperature but by the meeting of an amphiphile (a molecule with a water-loving head and an oil-loving tail) and water. Above a threshold concentration, amphiphilic lipids spontaneously self-assemble into highly regular nanostructures. The principal mesophases are the lamellar (stacked bilayers), the hexagonal (close-packed cylinders) and the bicontinuous cubic (two interpenetrating, continuous networks of water channels woven through a curved lipid bilayer).
Each of these is, in effect, a sponge built at the nanometre scale — with separate oil-like and water-like compartments, enormous internal surface area, and a geometry precise enough to meter what passes through it.
A liquid crystal flows like a liquid and remembers its shape like a crystal. That is exactly the combination a medicine wants.
GCC builds the structure
The lipid spine of Cinnamix is GCC — glyceryl caprate/caprylate, a medium-chain monoglyceride. Medium-chain monoglycerides are textbook amphiphiles, and in water they are known to self-organise into exactly these lyotropic liquid-crystalline mesophases. The behaviour is well characterised for the class: a cubic phase built specifically from a medium-chain lipid has been described and used to carry poorly water-soluble drugs, and related monoglyceride systems form cubic phases under the temperature and fluid conditions of the gut.
So GCC is not an inert solvent or oil. Presented with water, it organises itself into an ordered matrix — one with two distinct domains: the lipid bilayer regions, and the aqueous nanochannels that thread through them.
Where the cinnamate sits — and what it does to the structure
Here the molecule and the matrix fit together unusually well.
Potassium cinnamate is the water-soluble salt; it resides comfortably in the aqueous channels of the mesophase. Its parent, cinnamic acid, is the lipophilic, protonated form, which associates with the lipid bilayer regions. The active’s two forms map onto the matrix’s two domains — a salt in water, an acid in oil — with the local pH governing the balance between them.
And the cinnamate is not merely a passenger. Cinnamic acid has been shown to interact directly with a monoglyceride (monoolein) cubic phase, shifting its phase transition and producing pH-dependent release. In other words, the active itself can tune the structure that carries it — and the structure, in turn, can be made to release the active in response to its environment.
The salt rides the water channels; the acid sits in the lipid. The molecule’s two faces match the matrix’s two domains.
What the structure buys you that a solution cannot
A simple solution does one thing: it holds a molecule in water until it is poured out. An ordered liquid-crystalline matrix does considerably more, and each property is documented for the lipid liquid-crystal class:
Solubilisation across polarity. Because the matrix has both oil-like and water-like compartments, it can hold hydrophilic, lipophilic and amphiphilic molecules at once — a single vehicle for chemistries that would normally need different formulations.
Diffusion-controlled, sustained release. The tortuous nanochannels meter a molecule out rather than dumping it. Lipid liquid-crystalline mesophases are a recognised tool for sustained release; cubic-phase carriers have, for example, extended the absorption of a model poorly-soluble drug well beyond 48 hours in vivo. For an active the body clears in minutes, a matrix that releases over hours is the difference between a molecule that works and one that does not arrive.
Built-in structure and stability. A liquid crystal has a yield stress: it holds its shape, suspends particles evenly and resists separation, while still flowing when you want it to. That is what lets one fluid carry a dissolved active, suspended material and food-grade companions together without settling.
Environmental responsiveness. As the cinnamic-acid work shows, these phases can be engineered to change their release behaviour with pH — useful in a gastrointestinal tract that runs from acidic stomach to near-neutral intestine.
Why this is the right answer for cinnamate
Cinnamic acid’s therapeutic promise has always been undercut by one fact: it is absorbed and then cleared within minutes, with a half-life on the order of 30–40 minutes in animal models. A bare salt in water inherits that problem unchanged. An ordered matrix that solubilises the active, meters its release over time and responds to gut pH addresses the problem at its root. The limitation was never the molecule. It was the absence of a structure to carry it properly.
Not theoretical — and not new to medicine
Lipid liquid crystals are already a real, approved delivery technology. The clearest proof is Camurus’s FluidCrystal platform, behind the approved long-acting injectables Buvidal and Brixadi — regulators have accepted lipid liquid-crystalline delivery in marketed products. Cubosome and hexosome nanoparticles are an active and growing field across oral, injectable and topical routes.
Ibumix’s contribution is a specific one: a food-grade medium-chain lipid (GCC) forming the liquid-crystalline matrix, carrying a GRAS-status active (potassium cinnamate), aimed at oral and topical formats rather than implants. Familiar, accepted chemistry — arranged into an architecture that does new work.
The Cinnamix position
Cinnamix is potassium cinnamate built into a GCC liquid-crystalline matrix. The active is not floating in water; it is held inside an ordered structure that solubilises it, releases it on a controlled schedule, stabilises the whole system and can respond to its environment. The liquid has a skeleton — and the skeleton is doing the work.
It is the latest chassis on The Mix Platform, alongside Ibumix, Naproxymix and the polysorbate-class Sorbymix: one unified lipid-formulation architecture, several stand-alone chassis, each developable, partnerable or licensable on its own.
To be precise about status: the liquid-crystalline behaviour of medium-chain monoglycerides, and the specific interaction of cinnamic acid with a monoglyceride cubic phase, are established in the published literature. The exact phase behaviour and release profile of the Cinnamix formulation itself is the subject of development; proof-of-concept data is still to be generated. The architecture and the development target are what Ibumix is putting on record here.
Sources
- Lee et al. — Effect of cinnamic acid on phase transition and pH-dependent release of monoolein cubic phase
- A novel cubic phase of medium-chain lipid origin for poorly water-soluble drugs (Int. J. Pharm., 2004)
- Negrini & Mezzenga (2014) — Controlling molecular transport and sustained release in LC mesophases
- Chen et al. (2014) — Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems
- Oral and transdermal drug delivery: lipid-based lyotropic liquid crystals (review)
- Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems (2022)
- Cinnamic acid pharmacokinetics (Tmax ~15 min; t-half ~36 min), Eur. J. Drug Metab. Pharmacokinet. 2009
- Camurus FluidCrystal — the approved lipid liquid-crystal injectable platform (Buvidal / Brixadi)
This article is for information only and does not constitute medical advice or a therapeutic claim. The liquid-crystalline behaviour described is established for the lipid class in published research; the Cinnamix formulation’s own phase behaviour and performance are under development, with proof-of-concept data still to be generated.